Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03576417
Title A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck (NIVOPOSTOP)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Groupe Oncologie Radiotherapie Tete et Cou
Age Groups: adult | senior
Covered Countries FRA

Additional content available in CKB BOOST